Provided by Tiger Trade Technology Pte. Ltd.

MaxCyte Inc

1.09
-0.0300-2.68%
Post-market: 1.090.0004+0.04%17:59 EDT
Volume:397.06K
Turnover:438.13K
Market Cap:112.49M
PE:-3.27
High:1.16
Open:1.12
Low:1.08
Close:1.12
52wk High:1.87
52wk Low:0.6434
Shares:103.21M
Float Shares:92.68M
Volume Ratio:1.09
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3338
EPS(LYR):-0.4200
ROE:-20.39%
ROA:-10.64%
PB:0.71
PE(LYR):-2.60

Loading ...

Maxcyte® Announces Multi-platform Technology License Partnership with Genentech® to Advance Cell Therapy Development

THOMSON REUTERS
·
Jul 21

Maxcyte - Genentech to Access Maxcyte Expert Gtx Platform and Technologies for Cell Therapy Workflows

THOMSON REUTERS
·
Jul 21

MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026

GlobeNewswire
·
Jul 16

MaxCyte (MXCT) Receives a Buy from Craig-Hallum

TIPRANKS
·
Jul 04

Craig-Hallum Keeps Their Buy Rating on MaxCyte (MXCT)

TIPRANKS
·
Jun 25

Craig-Hallum Reaffirms Their Buy Rating on MaxCyte (MXCT)

TIPRANKS
·
Jun 18

MaxCyte Shareholders Reelect Directors and Ratify Auditor

TIPRANKS
·
Jun 18

MaxCyte shareholders approve CohnReznick as independent auditor for fiscal 2026

Reuters
·
Jun 18

MaxCyte Regains Nasdaq Compliance After Bid Price Recovery

TIPRANKS
·
Jun 17

MaxCyte regains Nasdaq compliance after shares trade above $1 for 10 days

Reuters
·
Jun 17

Analysts Offer Insights on Healthcare Companies: MaxCyte (MXCT) and Incyte (INCY)

TIPRANKS
·
Jun 11

MaxCyte (MXCT) Earnings Call: Cash-Rich, Growth Delayed

TIPRANKS
·
May 14

MaxCyte (MXCT) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
May 13

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR)

TIPRANKS
·
May 13

Stock Market Today: Dow Jones Futures Fall, S&P 500 Gains As Trump Takes Big Tech Leaders To China—Nvidia, Nextpower, Red Cat In Focus

Benzinga Earnings
·
May 13

Cisco, Alibaba And 3 Stocks To Watch Heading Into Wednesday

Benzinga Earnings
·
May 13

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ramsay Health Care (OtherRMSYF) and MaxCyte (MXCT)

TIPRANKS
·
May 13

MaxCyte backs FY26 revenue view $30M-$32M, consensus $30.83M

TIPRANKS
·
May 13

MaxCyte Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

MaxCyte Q1 FY26 net loss narrows to $4.8 million; revenue drops 7% to $9.7 million

Reuters
·
May 13